See generally https://
worksinprogress.co/issue/the-stor
y-of-vaccinateca/
… and California’s sudden nearly unanimous embrace of redlining in the provision of medical care.
@patio11
-
AI-driven redlining in California healthcare raises ethical concerns
By
–
-
U.S. Healthcare Institutions Prioritized Race Over Lives Saved
By
–
Sanity did not, in fact, prevail. Many governmental institutions in the U.S., including in California, did factually prioritize delivery of lifesaving medication by race, in the contemporaneous knowledge that this would pessimize for lives saved.
-
Claude’s Capability to Analyze Complex Publications and Social Situations
By
–
Claude, of course, can read high status publications and reason about complex social situations.
-
Market Delusion: Understanding Historical Trading Failures and Systemic Risk
By
–
(Not every bad trade in history is 2008 repeating itself, but it is instructive to understand how actors and systems can delude themselves.)
-
Regulation T leverage caps prevent risk race-to-bottom dynamics
By
–
“And do we see this in traditional markets like e.g. equities?” This is one reason why Reg T (et al) put a maximum cap on how much leverage brokers are allowed to offer given certain collateral to prevent race-to-the-bottom dynamics with risk tolerance.
-
Volatility Manufacturing and Leveraged ETF Market Dynamics
By
–
(As an intuitive sketch, the convert arb shops are manufacturing vol to both the upside and the downside, which they want to sell to willing buyers. The ETFs which pitch leveraged MSTR to retail buy one side of their outputs in size; the other side is industrial waste of that.)
-
Long-term put strategy for market asymmetry advantage
By
–
(Have had these puts for more than a year now on the general theory that I get few opportunities in the public markets to look at the other side of a trade and not feel like they have overwhelming advantage over me.)
-
MicroStrategy leverage and exchange token holder dynamics
By
–
(I understand that MicroStrategy is the opposite of leveraged exposure from the common shareholder’s perspective but if someone with hands on keyboard believes they are allowed leverage if they hold more exchange tokens then the model happens regardless of whether that is true.)
-
Risk Management Failures in AI Deployment Systems
By
–
And then “Holy %}*]^ how did so much of it end up in a place with grossly deficient risk management?!”
-
LLM Analysis of FDA Approval and Portfolio Strategy
By
–
You're welcome to ask an LLM that question but when I immediately followed up with it the LLM softened its language but not its conclusion, justifying this due to contemporaneous knowledge of FDA approval, the trivial cost, and portfolio management strategies.